In a previously reported split-mouth , randomized controlled trial , Miller Class II gingival recession defects were treated with either a connective tissue graft ( CTG ) ( control ) or recombinant human platelet-derived growth factor-BB + - tricalcium phosphate ( test ) , both in combination with a coronally advanced flap ( CAF ) .